Results 211 to 220 of about 86,934 (244)
Some of the next articles are maybe not open access.
Asymptomatic Peptic Ulcer Disease
Scandinavian Journal of Gastroenterology, 1987(1987). Asymptomatic Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology: Vol. 22, No. 2, pp. 129-134.
R, Jorde, P G, Burhol
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2011
Peptic ulcer disease (PUD) is due mostly to the widespread use of low-dose aspirin and nonsteroidal anti-inflammator drugs. It occurs mostly in older patients and those with comorbidities. Pain awakening the patient from sleep between 12 and 3 a.m. affects two-thirds of duodenal ulcer patients and one-third of gastric ulcer patients.
openaire +2 more sources
Peptic ulcer disease (PUD) is due mostly to the widespread use of low-dose aspirin and nonsteroidal anti-inflammator drugs. It occurs mostly in older patients and those with comorbidities. Pain awakening the patient from sleep between 12 and 3 a.m. affects two-thirds of duodenal ulcer patients and one-third of gastric ulcer patients.
openaire +2 more sources
Nature Clinical Practice Gastroenterology & Hepatology, 2006
Over the past few decades, since the introduction of histamine H(2)-receptor antagonists, proton-pump inhibitors, cyclo-oxygenase-2-selective anti-inflammatory drugs (coxibs), and eradication of Helicobacter pylori infection, the incidence of peptic ulcer disease and ulcer complications has decreased.
Yuhong, Yuan +2 more
openaire +2 more sources
Over the past few decades, since the introduction of histamine H(2)-receptor antagonists, proton-pump inhibitors, cyclo-oxygenase-2-selective anti-inflammatory drugs (coxibs), and eradication of Helicobacter pylori infection, the incidence of peptic ulcer disease and ulcer complications has decreased.
Yuhong, Yuan +2 more
openaire +2 more sources
Current Opinion in Gastroenterology, 2006
This review attempts to contextualize some of the clinically important publications of the last 2 years as they relate to the broad topic of dyspepsia and peptic ulcer disease, both Helicobacter pylori and nonsteroidal anti-inflammatory drug-related.This review includes findings which provide insight with regard to the triaging of dyspeptic subjects ...
openaire +2 more sources
This review attempts to contextualize some of the clinically important publications of the last 2 years as they relate to the broad topic of dyspepsia and peptic ulcer disease, both Helicobacter pylori and nonsteroidal anti-inflammatory drug-related.This review includes findings which provide insight with regard to the triaging of dyspeptic subjects ...
openaire +2 more sources
InnovAiT: Education and inspiration for general practice, 2014
Abstract A peptic ulcer is a persistent 5 mm or larger break in the gastrointestinal mucosa of the stomach or duodenum that penetrates through the muscularis mucosa. At endoscopy, an ulcer should be readily apparent with perceivable depth. Smaller and more shallow mucosal breaks represent erosions.
Nazia Hussain, Nailah Narra
openaire +2 more sources
Abstract A peptic ulcer is a persistent 5 mm or larger break in the gastrointestinal mucosa of the stomach or duodenum that penetrates through the muscularis mucosa. At endoscopy, an ulcer should be readily apparent with perceivable depth. Smaller and more shallow mucosal breaks represent erosions.
Nazia Hussain, Nailah Narra
openaire +2 more sources
Refractory Peptic Ulcer Disease
Gastroenterology Clinics of North America, 2009Refractory PUD is a diagnostic and therapeutic challenge. Optimal management of severe or refractory PUD requires a multidisciplinary team approach, using primary care providers, gastroenterologists, and general surgeons. Medical management has become the cornerstone of therapy.
openaire +2 more sources
Journal of the American Pharmaceutical Association (1961), 1971
J L, Hirschman, E T, Herfindal
openaire +2 more sources
J L, Hirschman, E T, Herfindal
openaire +2 more sources